160.62.22.0/24 RPKI valid
Announced by AS6095 Novartis Institutes for BioMedical Research, Inc.
Origin
| Origin AS | RPKI | Peers seeing it | Sample path | First seen | Last seen |
|---|---|---|---|---|---|
| AS6095 Novartis Institutes for BioMedical Research, Inc. | RPKI valid | 43 | 34549158306095 | 2026-09-18 | 2026-10-09 |
RPKI
4 ROAs cover this prefix
Registry
Who this address space is delegated to, regardless of whether it is routed
- Delegated block
- 160.62.0.0/16
- RIR
- RIPENCC
- Country
- 🇨🇠CH
- Status
- allocated
- Allocated
- 1992-08-03
Less specific routes
Announced prefixes that contain this one
Nothing less specific is announced.
More specific routes
0 announced prefixes inside this one
Nothing more specific is announced.